Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$35.68 - $44.71 $8,848 - $11,088
248 Added 8266.67%
251 $10,000
Q3 2022

Nov 08, 2022

SELL
$42.51 - $54.02 $3,400 - $4,321
-80 Reduced 96.39%
3 $0
Q2 2022

Jul 19, 2022

BUY
$46.84 - $59.75 $3,887 - $4,959
83 New
83 $4,000
Q3 2021

Oct 29, 2021

SELL
$56.91 - $67.81 $4,552 - $5,424
-80 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$64.02 - $71.72 $1,472 - $1,649
23 Added 40.35%
80 $5,000
Q1 2021

Apr 29, 2021

BUY
$53.26 - $68.08 $3,035 - $3,880
57 New
57 $4,000
Q4 2020

Jan 21, 2021

SELL
$43.41 - $56.51 $1,692 - $2,203
-39 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$47.43 - $60.75 $1,849 - $2,369
39 New
39 $2,000
Q1 2018

Apr 30, 2018

SELL
$46.03 - $61.28 $2,669 - $3,554
-58 Closed
0 $0
Q2 2017

Aug 10, 2017

BUY
N/A
58
58 $4,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.